Potential drug interactions in patients with mental disorders after infection with COVID-19

VernacularTitle:精神障碍患者感染新型冠状病毒后用药的潜在药物相互作用
Author: Yunai SU ¹ ; Yankun WU ¹ ; Youran DAI ¹ ; Tian SHEN ¹ ; Zhihui LAN ¹ ; Yaxin SUN ¹ ; Yulan XIONG ¹ ; Tianmei SI ¹
Author Information

1. 北京大学第六医院　北京大学精神卫生研究所　国家卫生健康委员会精神卫生学重点实验室（北京大学）国家精神心理疾病临床医学研究中心（北京大学第六医院），北京　100191
Publication Type:Journal Article
Keywords: Mental disorders; Psychotropic drugs; Drug interactions; 2019 nCoV
From: Chinese Journal of Psychiatry 2023;56(2):155-159
CountryChina
Language:Chinese
Abstract: Recently, the situation of the preventing and controlling of the novel coronavirus infection has changed. After patients with mental disorders are infected with the new coronavirus (hereinafter referred to as the new coronavirus), they will face the following problems: whether the drugs related to the new coronavirus infection can be used at the same time as the psychiatric drugs, and whether there will be pharmacokinetic or pharmacodynamic interactions between the medicines How to avoid the safety risks brought by drug interactions? Focusing on the above issues, this article puts forward some suggestions based on the summary of existing evidence, hoping to help front-line doctors.